- This event has passed.
EMBL Conference: Cancer Genomics
November 22 to November 24
EMBL is committed to sharing research advances and sustaining scientific interaction throughout the coronavirus pandemic. We are delighted to announce that this conference is going virtual and invite you to join us online.
This conference will provide an opportunity to learn about and keep up to date with the rapidly progressing area of cancer genomics. It will cover presentations from cancer genome projects, the areas of cancer functional genomics, systems biology, cancer immunogenomics and epigenomics, cancer mouse models and the translation and clinical impact of obtained scientific results. The meeting will bring together leading scientists from across these areas for a unique opportunity to interact and stimulate further integration of these efforts.
- Mutation and clonal selection in normal tissues
- Genomic instability and mutational processes
- Cancer evolution and drivers
- Emerging technologies in cancer genomics
- Cancer ecosystems, microenvironment and immunogenomics
- Cancer genome medicine
Jan Korbel, EMBL Heidelberg, Germany
Núria López-Bigas, Institute for Research in Biomedicine, Spain
Seishi Ogawa, Kyoto University, Japan
Elli Papaemmanuil, Memorial Sloan Kettering Cancer Center, USA
All our virtual courses provide hands on training and live interaction with word leading experts. We also provide a number of fee waivers (further information is available on Practical Information).